Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals Shares Outstanding 2010-2023 | VRTX

Vertex Pharmaceuticals shares outstanding history from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Vertex Pharmaceuticals shares outstanding for the quarter ending December 31, 2023 were 0.261B, a 0.54% increase year-over-year.
  • Vertex Pharmaceuticals 2023 shares outstanding were 0.261B, a 0.54% increase from 2022.
  • Vertex Pharmaceuticals 2022 shares outstanding were 0.259B, a 0.31% decline from 2021.
  • Vertex Pharmaceuticals 2021 shares outstanding were 0.26B, a 1.33% decline from 2020.
  
Vertex Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2023 261
2022 259
2021 260
2020 263
2019 261
2018 259
2017 253
2016 245
2015 241
2014 235
2013 225
2012 215
2011 209
2010 200
2009 173
Vertex Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2023-12-31 261
2023-09-30 261
2023-06-30 260
2023-03-31 260
2022-12-31 259
2022-09-30 260
2022-06-30 259
2022-03-31 258
2021-12-31 260
2021-09-30 260
2021-06-30 261
2021-03-31 262
2020-12-31 263
2020-09-30 264
2020-06-30 263
2020-03-31 264
2019-12-31 261
2019-09-30 260
2019-06-30 260
2019-03-31 260
2018-12-31 259
2018-09-30 260
2018-06-30 259
2018-03-31 259
2017-12-31 253
2017-09-30 250
2017-06-30 252
2017-03-31 249
2016-12-31 245
2016-09-30 245
2016-06-30 244
2016-03-31 244
2015-12-31 241
2015-09-30 242
2015-06-30 241
2015-03-31 239
2014-12-31 235
2014-09-30 236
2014-06-30 234
2014-03-31 233
2013-12-31 225
2013-09-30 231
2013-06-30 222
2013-03-31 215
2012-12-31 215
2012-09-30 214
2012-06-30 211
2012-03-31 219
2011-12-31 209
2011-09-30 219
2011-06-30 204
2011-03-31 202
2010-12-31 200
2010-09-30 201
2010-06-30 200
2010-03-31 199
2009-12-31 173
2009-09-30 179
2009-06-30 173
2009-03-31 156
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $101.699B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.933B 14.09
Regeneron Pharmaceuticals (REGN) United States $98.126B 23.79
Bristol Myers Squibb (BMY) United States $97.892B 6.44
CSL (CSLLY) Australia $84.007B 0.00
Gilead Sciences (GILD) United States $82.374B 9.85
GSK (GSK) United Kingdom $81.385B 10.20
Moderna (MRNA) United States $39.054B 0.00
Biogen (BIIB) United States $27.694B 12.93
Argenex SE (ARGX) Netherlands $21.255B 0.00
BioNTech SE (BNTX) Germany $20.485B 20.92
Genmab (GMAB) Denmark $18.733B 24.01
Illumina (ILMN) United States $18.584B 134.13
Alnylam Pharmaceuticals (ALNY) United States $18.282B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.999B 72.06
BeiGene (BGNE) Cayman Islands $12.621B 0.00
Incyte (INCY) United States $11.859B 19.71
Exact Sciences (EXAS) United States $11.524B 0.00
Sarepta Therapeutics (SRPT) United States $10.944B 0.00
Bio-Techne Corp (TECH) United States $9.779B 36.38
QIAGEN (QGEN) Netherlands $9.007B 18.64
Repligen (RGEN) United States $8.770B 90.79
Legend Biotech (LEGN) United States $8.572B 0.00
Roivant Sciences (ROIV) United Kingdom $8.349B 0.00
Ascendis Pharma (ASND) Denmark $8.203B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.983B 23.78
Viking Therapeutics (VKTX) United States $7.128B 0.00
Cytokinetics (CYTK) United States $7.007B 0.00
Intra-Cellular Therapies (ITCI) United States $6.970B 0.00
Exelixis (EXEL) United States $6.819B 35.14
Vaxcyte (PCVX) United States $6.593B 0.00
Apellis Pharmaceuticals (APLS) United States $5.729B 0.00
Blueprint Medicines (BPMC) United States $5.441B 0.00
Halozyme Therapeutics (HALO) United States $4.804B 14.83
CRISPR Therapeutics AG (CRSP) Switzerland $4.767B 0.00
Krystal Biotech (KRYS) United States $4.676B 0.00
Zealand Pharma (ZLDPF) Denmark $4.469B 0.00
Immunovant (IMVT) United States $4.115B 0.00
Nuvalent (NUVL) United States $4.040B 0.00
Alkermes (ALKS) Ireland $4.020B 21.21
Insmed (INSM) United States $3.684B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.570B 0.00
Biohaven (BHVN) United States $3.449B 0.00
ImmunityBio (IBRX) United States $3.324B 0.00
Iovance Biotherapeutics (IOVA) United States $3.273B 0.00
Fortrea Holdings (FTRE) United States $3.217B 0.00
SpringWorks Therapeutics (SWTX) United States $3.134B 0.00
Axsome Therapeutics (AXSM) United States $3.113B 0.00
Amicus Therapeutics (FOLD) United States $3.051B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.041B 0.00
Arcellx (ACLX) United States $2.904B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.851B 0.00
Apogee Therapeutics (APGE) United States $2.826B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.813B 0.00
IDEAYA Biosciences (IDYA) United States $2.805B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.727B 0.00
MorphoSys AG (MOR) Germany $2.719B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.699B 0.00
Certara (CERT) United States $2.597B 55.90
Janux Therapeutics (JANX) United States $2.524B 0.00
Merus (MRUS) Netherlands $2.375B 0.00
CG Oncology (CGON) United States $2.354B 0.00
Arvinas (ARVN) United States $2.342B 0.00
Denali Therapeutics (DNLI) United States $2.310B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.292B 0.00
Celldex Therapeutics (CLDX) United States $2.154B 0.00
Vera Therapeutics (VERA) United States $2.150B 0.00
Kymera Therapeutics (KYMR) United States $2.146B 0.00
Keros Therapeutics (KROS) United States $2.126B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.125B 0.00
Vericel (VCEL) United States $2.122B 0.00
Intellia Therapeutics (NTLA) United States $2.056B 0.00
Geron (GERN) United States $2.040B 0.00
Guardant Health (GH) United States $2.029B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.990B 0.00
Beam Therapeutics (BEAM) United States $1.985B 0.00
Galapagos (GLPG) Belgium $1.905B 0.00
Avidity Biosciences (RNA) United States $1.837B 0.00
NeoGenomics (NEO) United States $1.758B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.741B 0.00
Sana Biotechnology (SANA) United States $1.704B 0.00
Structure Therapeutics (GPCR) United States $1.686B 0.00
Neumora Therapeutics (NMRA) United States $1.676B 0.00
Myriad Genetics (MYGN) United States $1.675B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.649B 13.69
Twist Bioscience (TWST) United States $1.640B 0.00
Inhibrx (INBX) United States $1.633B 0.00
Bavarian Nordic (BVNRY) Denmark $1.621B 5.32
Dynavax Technologies (DVAX) United States $1.484B 0.00
Protagonist Therapeutics (PTGX) United States $1.470B 0.00
Edgewise Therapeutics (EWTX) United States $1.439B 0.00
Akero Therapeutics (AKRO) United States $1.418B 0.00
ADMA Biologics Inc (ADMA) United States $1.415B 0.00
Zai Lab (ZLAB) China $1.411B 0.00
Morphic Holding (MORF) United States $1.377B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.376B 0.00
ANI Pharmaceuticals (ANIP) United States $1.361B 16.73
Arcus Biosciences (RCUS) United States $1.348B 0.00
Kura Oncology (KURA) United States $1.347B 0.00
Gyre Therapeutics (GYRE) United States $1.316B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.301B 0.00
Spyre Therapeutics (SYRE) United States $1.286B 0.00
Ligand Pharmaceuticals (LGND) United States $1.284B 15.90
Autolus Therapeutics (AUTL) United Kingdom $1.276B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.192B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.150B 0.00
AbCellera Biologics (ABCL) Canada $1.145B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.124B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.108B 0.00
Prothena (PRTA) Ireland $1.105B 0.00
MannKind (MNKD) United States $1.104B 0.00
Scholar Rock Holding (SRRK) United States $1.086B 0.00
Vir Biotechnology (VIR) United States $1.071B 0.00
Liquidia Technologies (LQDA) United States $1.050B 0.00
Immunome (IMNM) United States $1.026B 0.00
Belite Bio (BLTE) United States $1.009B 0.00
Viridian Therapeutics (VRDN) United States $0.952B 0.00
Abivax SA (ABVX) France $0.951B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.915B 0.00
MiMedx (MDXG) United States $0.905B 205.33
Adaptimmune Therapeutics (ADAP) United Kingdom $0.893B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.890B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.872B 0.00
Immatics (IMTX) Germany $0.869B 0.00
89BIO (ETNB) United States $0.846B 0.00
Kyverna Therapeutics (KYTX) United States $0.820B 0.00
REGENXBIO (RGNX) United States $0.790B 0.00
ALX Oncology Holdings (ALXO) United States $0.787B 0.00
Tango Therapeutics (TNGX) United States $0.787B 0.00
Cytek Biosciences (CTKB) United States $0.780B 0.00
Cullinan Oncology (CGEM) United States $0.778B 0.00
Tyra Biosciences (TYRA) United States $0.770B 0.00
CARGO Therapeutics (CRGX) United States $0.752B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.736B 0.00
Pliant Therapeutics (PLRX) United States $0.734B 0.00
PureTech Health (PRTC) United States $0.727B 0.00
Disc Medicine (IRON) United States $0.725B 0.00
Nurix Therapeutics (NRIX) United States $0.710B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.708B 0.00
Dianthus Therapeutics (DNTH) United States $0.694B 0.00
Cabaletta Bio (CABA) United States $0.674B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.657B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.649B 0.00
Oric Pharmaceuticals (ORIC) United States $0.641B 0.00
Cogent Biosciences (COGT) United States $0.632B 0.00
Pharming Group (PHAR) Netherlands $0.626B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.626B 0.00
Pharming Group (PHGUF) Netherlands $0.620B 0.00
EnGene Holdings (ENGN) United States $0.618B 0.00
Praxis Precision Medicines (PRAX) United States $0.617B 0.00
Northwest Biotherapeutics (NWBO) United States $0.614B 0.00
Zymeworks (ZYME) United States $0.612B 0.00
Aerovate Therapeutics (AVTE) United States $0.602B 0.00
HilleVax (HLVX) United States $0.590B 0.00
WAVE Life Sciences (WVE) Singapore $0.587B 0.00
Allogene Therapeutics (ALLO) United States $0.585B 0.00
Mesoblast (MESO) Australia $0.583B 0.00
GH Research (GHRS) Ireland $0.582B 0.00
Astria Therapeutics (ATXS) United States $0.579B 0.00
Fate Therapeutics (FATE) United States $0.574B 0.00
Nuvation Bio (NUVB) United States $0.563B 0.00
Absci (ABSI) United States $0.561B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.555B 0.00
Olema Pharmaceuticals (OLMA) United States $0.554B 0.00
Prime Medicine (PRME) United States $0.551B 0.00
CureVac (CVAC) Germany $0.546B 0.00
Novavax (NVAX) United States $0.544B 0.00
Stoke Therapeutics (STOK) United States $0.539B 0.00
Mineralys Therapeutics (MLYS) United States $0.534B 0.00
AnaptysBio (ANAB) United States $0.531B 0.00
Castle Biosciences (CSTL) United States $0.527B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
ArriVent BioPharma (AVBP) United States $0.519B 0.00
Applied Therapeutics (APLT) United States $0.502B 0.00
Celcuity (CELC) United States $0.499B 0.00
Arbutus Biopharma (ABUS) United States $0.490B 0.00
Alector (ALEC) United States $0.487B 0.00
Shattuck Labs (STTK) United States $0.481B 0.00
ACELYRIN, INC (SLRN) United States $0.480B 0.00
Oculis Holding AG (OCS) Switzerland $0.477B 0.00
C4 Therapeutics (CCCC) United States $0.474B 0.00
Third Harmonic Bio (THRD) United States $0.465B 0.00
Editas Medicine (EDIT) United States $0.456B 0.00
Travere Therapeutics (TVTX) United States $0.441B 0.00
Fulcrum Therapeutics (FULC) United States $0.437B 0.00
IGM Biosciences (IGMS) United States $0.436B 0.00
Replimune (REPL) United States $0.428B 0.00
Humacyte (HUMA) United States $0.428B 0.00
Avid Bioservices (CDMO) United States $0.412B 0.00
Voyager Therapeutics (VYGR) United States $0.410B 2.44
Neurogene (NGNE) United States $0.406B 0.00
Mersana Therapeutics (MRSN) United States $0.405B 0.00
MaxCyte (MXCT) United States $0.405B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.401B 0.00
Biomea Fusion (BMEA) United States $0.401B 0.00
Entrada Therapeutics (TRDA) United States $0.400B 0.00
Annexon (ANNX) United States $0.400B 0.00
Revance Therapeutics (RVNC) United States $0.395B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.394B 0.00
Adlai Nortye (ANL) Cayman Islands $0.393B 0.00
Nkarta (NKTX) United States $0.385B 0.00
PepGen (PEPG) United States $0.383B 0.00
Anika Therapeutics (ANIK) United States $0.378B 0.00
ITeos Therapeutics (ITOS) United States $0.370B 0.00
Alto Neuroscience (ANRO) United States $0.363B 0.00
FibroBiologics (FBLG) United States $0.359B 0.00
Amarin (AMRN) Ireland $0.358B 0.00
Caribou Biosciences (CRBU) United States $0.353B 0.00
Solid Biosciences (SLDB) United States $0.350B 0.00
Jasper Therapeutics (JSPR) United States $0.350B 0.00
Aura Biosciences (AURA) United States $0.350B 0.00
Ocugen (OCGN) United States $0.340B 0.00
Adaptive Biotechnologies (ADPT) United States $0.339B 0.00
Tenaya Therapeutics (TNYA) United States $0.337B 0.00
Urogen Pharma (URGN) United States $0.334B 0.00
TScan Therapeutics (TCRX) United States $0.331B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.331B 0.00
Renovaro (RENB) United States $0.330B 0.00
Precigen (PGEN) United States $0.329B 0.00
MeiraGTx Holdings (MGTX) United States $0.322B 0.00
Anavex Life Sciences (AVXL) United States $0.312B 0.00
Atea Pharmaceuticals (AVIR) United States $0.311B 0.00
Ventyx Biosciences (VTYX) United States $0.307B 0.00
Rani Therapeutics Holdings (RANI) United States $0.303B 0.00
CorMedix Inc (CRMD) United States $0.297B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.297B 0.00
Terns Pharmaceuticals (TERN) United States $0.297B 0.00
Kamada (KMDA) Israel $0.293B 22.17
Nautilus Biotechnology (NAUT) United States $0.293B 0.00
XOMA (XOMA) United States $0.286B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.286B 99.40
ChromaDex (CDXC) United States $0.285B 0.00
Inozyme Pharma (INZY) United States $0.283B 0.00
Contineum Therapeutics (CTNM) United States $0.283B 0.00
Invivyd (IVVD) United States $0.280B 0.00
Rapt Therapeutics (RAPT) United States $0.276B 0.00
Erasca (ERAS) United States $0.271B 0.00
Verastem (VSTM) United States $0.259B 0.00
Werewolf Therapeutics (HOWL) United States $0.254B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.252B 0.00
23andMe Holding (ME) United States $0.244B 0.00
XBiotech (XBIT) United States $0.241B 0.00
Puma Biotechnology (PBYI) United States $0.241B 10.85
Inovio Pharmaceuticals (INO) United States $0.238B 0.00
2seventy Bio (TSVT) United States $0.238B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
AC Immune (ACIU) Switzerland $0.235B 0.00
Adverum Biotechnologies (ADVM) United States $0.231B 0.00
Coherus BioSciences (CHRS) United States $0.227B 0.00
Ovid Therapeutics (OVID) United States $0.227B 0.00
UniQure (QURE) Netherlands $0.225B 0.00
G1 Therapeutics (GTHX) United States $0.218B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.213B 0.00
Design Therapeutics (DSGN) United States $0.211B 0.00
Skye Bioscience (SKYE) United States $0.210B 0.00
Abeona Therapeutics (ABEO) United States $0.206B 0.00
Compass Therapeutics (CMPX) United States $0.205B 0.00
X4 Pharmaceuticals (XFOR) United States $0.202B 0.00
Opthea (OPT) Australia $0.199B 0.00
Codexis (CDXS) United States $0.197B 0.00
Cardiff Oncology (CRDF) United States $0.195B 0.00
Elevation Oncology (ELEV) United States $0.195B 0.00
Prima BioMed (IMMP) Australia $0.193B 0.00
Poseida Therapeutics (PSTX) United States $0.193B 0.00
Lifecore Biomedical (LFCR) United States $0.191B 0.00
Innate Pharma S.A (IPHA) France $0.190B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.190B 0.00
Akoya Biosciences (AKYA) United States $0.189B 0.00
Trevi Therapeutics (TRVI) United States $0.185B 0.00
Kodiak Sciences (KOD) United States $0.182B 0.00
Gossamer Bio (GOSS) United States $0.182B 0.00
Inventiva S.A (IVA) France $0.181B 0.00
Alimera Sciences (ALIM) United States $0.180B 0.00
GENFIT S.A (GNFT) France $0.179B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.169B 0.00
Adicet Bio (ACET) United States $0.166B 0.00
Greenwich LifeSciences (GLSI) United States $0.166B 0.00
Compugen (CGEN) Israel $0.163B 0.00
ScPharmaceuticals (SCPH) United States $0.163B 0.00
Candel Therapeutics (CADL) United States $0.160B 0.00
INmune Bio (INMB) United States $0.160B 0.00
BioStem Technologies (BSEM) $0.159B 0.00
Zura Bio (ZURA) United States $0.159B 0.00
CervoMed (CRVO) United States $0.156B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.151B 0.00
Scilex Holding (SCLX) United States $0.150B 0.00
I-Mab (IMAB) China $0.145B 0.00
Cellectis S.A (CLLS) France $0.137B 0.00
Molecular Partners AG (MOLN) Switzerland $0.136B 0.00
Omega Therapeutics (OMGA) United States $0.133B 0.00
Rezolute (RZLT) United States $0.132B 0.00
DBV Technologies S.A (DBVT) France $0.127B 0.00
VistaGen Therapeutics (VTGN) United States $0.127B 0.00
TELA Bio (TELA) United States $0.127B 0.00
Sagimet Biosciences (SGMT) United States $0.127B 0.00
Syros Pharmaceuticals (SYRS) United States $0.126B 0.00
Coya Therapeutics (COYA) United States $0.123B 0.00
Nuvectis Pharma (NVCT) United States $0.119B 0.00
CytomX Therapeutics (CTMX) United States $0.117B 0.00
BioAtla (BCAB) United States $0.117B 0.00
Adagene (ADAG) China $0.116B 0.00
Vor Biopharma (VOR) $0.115B 0.00
Immunic (IMUX) United States $0.114B 0.00
Seer (SEER) United States $0.113B 0.00
Repare Therapeutics (RPTX) Canada $0.112B 0.00
BioHarvest Sciences (CNVCF) Canada $0.110B 0.00
ATyr Pharma (LIFE) United States $0.110B 0.00
Annovis Bio (ANVS) United States $0.108B 0.00
Oncobiologics (OTLK) United States $0.108B 0.00
PDS Biotechnology (PDSB) United States $0.106B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.105B 0.00
Bluebird Bio (BLUE) United States $0.104B 0.00
Agenus (AGEN) United States $0.104B 0.00
Genelux (GNLX) United States $0.104B 0.00
Vigil Neuroscience (VIGL) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.099B 0.00
Clearside Biomedical (CLSD) United States $0.099B 0.00
Emergent Biosolutions (EBS) United States $0.097B 0.00
IO Biotech (IOBT) Denmark $0.097B 0.00
DiaMedica Therapeutics (DMAC) United States $0.095B 0.00
Cartesian Therapeutics (RNAC) United States $0.093B 0.00
Allakos (ALLK) United States $0.093B 0.00
Curis (CRIS) United States $0.090B 0.00
Seres Therapeutics (MCRB) United States $0.088B 0.00
Sangamo Therapeutics (SGMO) United States $0.087B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.087B 0.00
Galena Biopharma (SLS) United States $0.086B 0.00
Aileron Therapeutics (ALRN) United States $0.085B 0.00
Elicio Therapeutics (ELTX) United States $0.084B 0.00
Connect Biopharma Holdings (CNTB) United States $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.083B 0.00
Alpha Teknova (TKNO) United States $0.082B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.082B 0.00
YS Biopharma (YS) China $0.080B 0.00
Q32 Bio (QTTB) United States $0.079B 0.00
Spero Therapeutics (SPRO) United States $0.079B 2.94
Athira Pharma (ATHA) United States $0.079B 0.00
Eton Pharmaceuticals (ETON) United States $0.079B 0.00
BioXcel Therapeutics (BTAI) United States $0.078B 0.00
Oncolytics Biotech (ONCY) Canada $0.078B 0.00
Affimed (AFMD) Germany $0.077B 0.00
Cue Biopharma (CUE) United States $0.077B 0.00
Leap Therapeutics (LPTX) United States $0.076B 0.00
HOOKIPA Pharma (HOOK) United States $0.076B 0.00
VTv Therapeutics (VTVT) United States $0.074B 0.00
InflaRx (IFRX) Germany $0.074B 0.00
Precision BioSciences (DTIL) United States $0.074B 0.00
Elutia (ELUT) United States $0.074B 0.00
Passage Bio (PASG) United States $0.074B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.073B 0.00
Gritstone Bio (GRTS) United States $0.073B 0.00
Cognition Therapeutics (CGTX) United States $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
AN2 Therapeutics (ANTX) United States $0.071B 0.00
BeyondSpring (BYSI) United States $0.070B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.069B 0.00
MediciNova (MNOV) United States $0.069B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.068B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.068B 0.00
Landos Biopharma (LABP) United States $0.068B 0.00
Instil Bio (TIL) United States $0.068B 0.00
Cidara Therapeutics (CDTX) United States $0.065B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Ocean Biomedical (OCEA) United States $0.064B 0.00
LENZ Therapeutics (LENZ) United States $0.064B 0.00
Rallybio (RLYB) United States $0.063B 0.00
HCW Biologics (HCWB) United States $0.063B 0.00
Turnstone Biologics (TSBX) United States $0.063B 0.00
Celularity (CELU) United States $0.062B 0.00
Lantern Pharma (LTRN) United States $0.062B 0.00
Kronos Bio (KRON) United States $0.062B 0.00
Equillium (EQ) United States $0.061B 0.00
Ikena Oncology (IKNA) United States $0.061B 0.00
Aligos Therapeutics (ALGS) United States $0.060B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
Vaxxinity (VAXX) United States $0.059B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Enzo Biochem (ENZ) United States $0.058B 0.00
Kezar Life Sciences (KZR) United States $0.057B 0.00
Checkpoint Therapeutics (CKPT) United States $0.057B 0.00
AVROBIO (AVRO) United States $0.056B 0.00
Intensity Therapeutics (INTS) United States $0.052B 0.00
Immuneering (IMRX) United States $0.052B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.049B 0.00
ARCA Biopharma (ABIO) United States $0.047B 0.00
Dyadic (DYAI) United States $0.046B 0.00
Quince Therapeutics (QNCX) United States $0.046B 0.00
Apollomics (APLM) United States $0.046B 0.00
Aadi Bioscience (AADI) United States $0.044B 0.00
Xilio Therapeutics (XLO) United States $0.044B 0.00
NextCure (NXTC) United States $0.044B 0.00
Bolt Biotherapeutics (BOLT) United States $0.043B 0.00
Carmell (CTCX) United States $0.043B 0.00
CalciMedica (CALC) United States $0.043B 0.00
Bionano Genomics (BNGO) United States $0.043B 0.00
Beyond Air (XAIR) United States $0.043B 0.00
Clene (CLNN) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.042B 0.00
Ocuphire Pharma (OCUP) United States $0.041B 0.00
SAB Biotherapeutics (SABS) United States $0.041B 0.00
Promis Neurosciences (PMN) Canada $0.038B 0.00
Cara Therapeutics (CARA) United States $0.038B 0.00
Estrella Immunopharma (ESLA) United States $0.038B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.035B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
Cyclo Therapeutics (CYTH) United States $0.034B 0.00
BRIACELL THERAP (BCTX) Canada $0.034B 0.00
IN8bio (INAB) United States $0.034B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.034B 0.00
Semper Paratus Acquisition (TVGN) United States $0.034B 0.00
BioAffinity Technologies (BIAF) United States $0.032B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.032B 0.00
Theratechnologies (THTX) Canada $0.032B 0.00
Aprea Therapeutics (APRE) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Dare Bioscience (DARE) United States $0.030B 0.00
Prenetics Global (PRE) Cayman Islands $0.029B 0.00
Lexaria Bioscience (LEXX) Canada $0.029B 0.00
Femasys (FEMY) United States $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Forte Biosciences (FBRX) United States $0.028B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Pluri (PLUR) Israel $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Eyenovia (EYEN) United States $0.025B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Synlogic (SYBX) United States $0.021B 0.00
Lumos Pharma (LUMO) United States $0.021B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.021B 0.00
RenovoRx (RNXT) United States $0.021B 0.00
Aptose Biosciences (APTO) Canada $0.020B 0.00
NKGen Biotech (NKGN) United States $0.020B 0.00
Galecto (GLTO) Denmark $0.020B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
KALA BIO (KALA) United States $0.019B 0.00
VBI Vaccines (VBIV) United States $0.018B 0.00
Benitec Biopharma (BNTC) United States $0.018B 0.00
Orgenesis (ORGS) United States $0.018B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.017B 0.00
Talis Biomedical (TLIS) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Senti Biosciences (SNTI) United States $0.013B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Monopar Therapeutics (MNPR) United States $0.012B 0.00
Purple Biotech (PPBT) Israel $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.012B 0.00
Organovo Holdings (ONVO) United States $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Galera Therapeutics (GRTX) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Telesis Bio (TBIO) United States $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
Chemomab Therapeutics (CMMB) Israel $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Psyence Biomedical (PBM) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
PaxMedica (PXMD) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Kineta (KA) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Longeveron (LGVN) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.34
TRACON Pharmaceuticals (TCON) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.005B 0.00
Seelos Therapeutics (SEEL) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
Kintara Therapeutics (KTRA) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.000B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00